Cancer Screening
’Breathe Easy’ bus brings lung screening to areas where it’s needed most
J. Rob Headrick, MD, MBA, understands the psychology of smokers.
Delays in cancer diagnoses amid COVID-19 signal downstream effect on long-term outcomes
Strategies must be implemented to ensure individuals receive appropriate cancer screening and care amid the COVID-19 pandemic, according to studies presented at American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer.
COVID-19 pandemic causing ‘unprecedented disruption’ in cancer research, Fauci says
The COVID-19 pandemic likely will have a significant long-term effect on the diagnosis and treatment of cancer, Anthony S. Fauci, MD, said today during an American Association for Cancer Research virtual meeting on COVID-19 and cancer.
Top in hem/onc: Lung cancer screening, liquid biopsy
The U.S. Preventive Services Task Force has issued a draft recommendation that lowers the age to begin lung cancer screening in individuals with a history of smoking. It was the top story in hematology/oncology last week.
Draft USPSTF guidance lowers recommended age to start lung cancer screening
Individuals with a smoking history should begin annual screening for lung cancer at age 50 years instead of age 55 years, according to a draft recommendation issued by the U.S. Preventive Services Task Force.
Early breast cancer screening lowers mortality risk among childhood cancer survivors
Female childhood cancer survivors aged 25 to 35 years who underwent annual breast cancer screening via MRI with or without mammography lowered their risk for breast cancer mortality, according to results from a comparative modeling study.
36% of US counties with high lung cancer rates at least 1 hour from screening center
A new study identified U.S. counties with high rates of lung cancer where travel times to a dedicated screening center exceed 60 minutes.
Community lung cancer screening results comparable to national trial
The generalizability of the National Lung Screening Trial to community health settings was confirmed in a recent analysis, researchers said.
Mammography for women aged 40 to 49 years associated with high, widely variable costs
The value of routine screening mammography for women aged 40 to 49 years has been a topic of debate, particularly when weighing the clinical benefits against the risks.
Barriers to screening for HCC are ‘multiple and at different levels’
Hepatocellular carcinoma is the most common type of liver cancer worldwide. Individuals who have been diagnosed with hepatitis B, hepatitis C or cirrhosis have the highest risk for developing HCC. While the incidence rate decreased among younger and middle-aged adults between 1992 and 2015, the overall incidence rate of HCC in the United States increased from 4.1 cases per 100,000 people in 1992 to 9.5 in 2015.